<i>TERT</i> promoter mutations in thyroid cancer
Author:
Affiliation:
1. Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0136/_pdf
Reference142 articles.
1. 1 Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, et al. (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339: 957–959.
2. 2 Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, et al. (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339: 959–961.
3. 3 Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, et al. (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A 110: 17426–17431.
4. 4 Chen C, Han S, Meng L, Li Z, Zhang X, et al. (2014) TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas. PLoS One 9: e100297.
5. 5 Andres-Lencina JJ, Rachakonda S, Garcia-Casado Z, Srinivas N, Skorokhod A, et al. (2019) TERT promoter mutation subtypes and survival in stage I and II melanoma patients. Int J Cancer 144: 1027–1036.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma;Anticancer Research;2024-06-26
2. Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer;Biomedicines;2024-06-10
3. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study;Clinical and Experimental Medicine;2024-04-12
4. TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-04-05
5. Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay;The Journal of Clinical Endocrinology & Metabolism;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3